antibodies produced against pig heart lipoamide dehydrogenase cross-react with BCOAD, pyruvate dehydrogenase and 2-oxoglutarate dehydrogenase complexes, giving further evidence for the commonality of this subunit among these three mitochondrial complexes.
Branched-chain 2-oxo acid dehydrogenase (BCOAD; EC 1.2.4.4) is a multienzyme complex associated with the mitochondrial inner membrane of most mammalian tissues. The complex catalyses the oxidative decarboxylation of branched-chain 2-oxo acids (BCOA) via three enzyme components: a decarboxylase (El), which releases CO2, a core transacylase (E2), which transfers an acyl group to CoA, and lipoamide dehydrogenase (E3), which reduces NAD+ to NADH + H+:
whole-animal studies utilizing hormone and diet manipulation suggest that BCOAD activity may vary from tissue to tissue within a species (Odessey & Goldberg, 1972; Dohm et al., 1976; Barakat et al., 1977; Paul & Adibi, 1978 , 1980 Buse, 1981) . However, the inherited human disorder, branchedchain 2-oxoacidaemia, affects the function of BCOAD in all tissues of homozygous affected individuals (Dancis et al., 1960 (Dancis et al., , 1963 CO2 + acyl-CoA + NADH + H+ This reaction is similar to that catalysed by the pyruvate dehydrogenase (EC 1.2.4.1) and 2-oxoglutarate dehydrogenase (EC 1.2.4.2) complexes. All three complexes are thought to be functionally similar and contain identical E3 subunits, although the El and E2 subunits are unique for each complex (Danner et al., 1979; Pettit et al., 1978) . (Hughes & Halestrap, 1981; Lau et al., 1981; Paul & Adibi, 1982) .
Branched-chain 2-oxoacidaemia is an interesting disorder in that the altered BCOAD function varies from family to family and even within a family. 
Materials and methods
All reagents were of the highest grade available and solutions were made in deionized water. 1-14C-labelled 2-oxo acids were prepared from precursor amino acids as previously described (Elsas et al., 1974) . Protein concentration was determined by the method of Bradford (1976) . A Gilford 250 recording spectrophotometer interfaced with an Apple II Plus microcomputer was used for spectral analysis.
Preparation ofantisera
Antibodies were produced in New Zealand White rabbits (Gilreath) by multiple subcutaneous injections of the protein in Freund's adjuvant (Difco). Injection schedules were as follows: pig heart lipoamide dehydrogenase (Sigma) was injected at a concentration of 0.75mg every 2 weeks; in separate rabbits, 0.3pug of bovine liver BCOAD prepared as previously described (Heffelfinger, 1983) was injected on 3 consecutive. days, followed by 0.1mg booster injections at monthly intervals. The Ig fraction was prepared from the antisera by precipitation with 50% of (NH4)2SO4. Ig was stored in 50mM-potassium phosphate, pH7.0, at 25mg/ml and -200C. Preparation of Fab fragments (Spiegelberg & Weigle, 1965) IgG was prepared from the Ig fraction by DEAE-cellulose chromatography. After binding the Ig in 5mM-potassium phosphate, pH8.0, the IgG was eluted from the column with 35mM-potassium phosphate, pH 8.0. Papain digestion of the IgG (1 mg of papain/lOOmg of Ig) was stopped after 6h at 370C in 150mM-potassium phosphate, pH 7.0, containing 0.01 M-cysteine hydrochloride and 2.0 mM-EDTA. The digest was dialysed against 10mM-acetate buffer, pH5.5. Fab fragments were separated from Fc fragments and undigested IgG by CM-cellulose column chromatography (Porter, 1959) . SDS/polyacrylamide-gel electrophoresis of the unbound fraction showed the Fab fragment as a single protein band, with Mr 40 000.
Immunoelectrophoresis
Rocket immunoelectrophoresis was performed with a 1% agarose gel containing 2% Ig fraction and 1% Triton X-100. Electrophoresis took 15-18h at 120V and 40C, in a Tris/borate buffer, pH8.6. After electrophoresis the gels were washed consecutively in 0.2M-NaCl, water and 12.5% trichloroacetic acid. Precipitated antigen-antibody complexes were stained with 0.0125% Coomassie Brilliant Blue G in 12.5% trichloroacetic acid.
Mitochondrial-inner-membrane preparation
Fibroblasts were washed in 0.25 M-sucrose/ 0.1 mM-EDTA/I mM-potassium phosphate, pH 7.2, and centrifuged at 700g for 5 min. The cell pellet was mixed with the same buffer at a ratio of 400mg wet wt./lOml of buffer. For every 10ml of cell suspension, 25,ul of Protease VI (Sigma) (0.1 mg/ml) was added and digestion was allowed to proceed for 7min at 00C. The cells were homogenized in a glass/Teflon grinder and the volume was doubled with buffer. Whole cells and nuclei were removed by centrifugation at 700g for 10min, and the mitochondrial fraction was precipitated by centrifugation at 100OOg for 10min. This mitochondrial pellet was suspended in a minimal volume of buffer and the outer membrane was stripped by digitonin treatment (1 mg of digitonin/mg of mitochondrial protein). After 20min exposure to the detergent, the reaction volume was doubled with buffer and the inner-membrane fraction pelleted by centrifugation at 15000gfor 15 min.
Mitochondria from animal tissues were prepared by conventional methods of differential centrifugation of tissue homogenates in the sucrose/ EDTA/phosphate buffer. Inner membranes were prepared with digitonin treatment as for fibroblast mitochondria, or a soluble fraction was made from the mitochondria by suspending the mitochondria in 20mM-phosphate buffer, pH 6.5, and freezing at -70°C and then centrifuging the thawed solution at 300000g for 45 min. Western blot (Burnette, 1981) Protein samples in duplicate were resolved by electrophoresis on a SDS/10% polyacrylamide gel, and the gel was soaked for 30min with two changes in 25 mM-Tris/glycine, pH 8.3, diluted with 0.2 vol of methanol. Electroblotting was done in an E-C Electroblot apparatus (E-C Apparatus Corp., St. Petersburg, FL, U.S.A.) on to nitrocellulose according to the manufacturer's instructions. Blotting took less than 4h at 300mA. After blotting, the nitrocellulose was soaked in 0.15 M-NaCl/0.05 M-Tris/ HCI (pH 7.4) containing 1% gelatin (Sigma type III) and 0.1 % Tween 20 (Medium I) for 60 min. Protein-impregnated nitrocellulose was cut into duplicate pieces and each was incubated for 1 h in Branched-chain 2-oxo acid dehydrogenase 2ml of bovine serum + 36 ml of 0.15 M-NaCl/0.05 MTris/HCl (pH 7.4) containing 0.1% Tween 20, 0.005 M-EDTA and 0.25% gelatin (Medium II). To each solution 50,u1 of specific or control antiserum was added, and the nitrocellulose strips were allowed to incubate overnight at room temperature. The blots were rinsed for a minimum of 3 x 10 min with Medium II and incubated for 2h with 60,u1 of horseradish peroxidase-conjugated goat anti-(rabbit IgG) IgG and 300,ul of bovine serum in 12 ml of Medium II. Each strip was then rinsed for 4 x 10min with Medium II, and the peroxidase reaction was developed with freshly prepared 3,3'-diaminobenzidine tetrahydrochloride (Sigma) (60mg in 200ml of 0.005 M-Tris/HCl, pH 7.5, +33 ,u1 of 30% H202). (Care: this is a carcinogen.) The colour reaction was stopped by rinsing in water.
Enzyme assays BCOAD complex activity was measured by quantifying the formation of NADH by using the increase in A340 with time. Assay conditions have been described (Danner et al., 1979) , and the mixture contains, in 500,ul: 30 mM-potassium phosphate, pH 7.5, 5 mM-dithiothreitol, 100 pg of bovine serum albumin, 0.5 mM-CoA, 1 mM-NAD+, 0.2 mM-thiamin pyrophosphate, 0.2mM-MgCl2, 1-50,ug of enzyme protein, and 0.1mm oxo acid to start the reaction. When 14CO2 was used to measure activity the reaction mixture was contained in 250 p1 and 1-14C-labelled oxo acid served as substrate.
Results
Immunoglobulin from rabbits sensitized with bovine liver BCOAD specifically inhibited catalytic activity of this enzyme complex when production of either CO2 or NADH was used to quantify the function of the complex. As shown in Fig. 1(a) Antisera were also prepared against pig heart lipoamide dehydrogenase, the putative E3 of BCOAD as well as of pyruvate dehydrogenase and 2-oxoglutarate dehydrogenase complexes. IgG fraction prepared from the sera was able to inhibit NADH production by BCOAD (Fig. lb) , suggesting that antigenic determinants similar to lipoamide dehydrogenase are in the E3 component of BCOAD complex. A 50% inhibition occurred at a protein ratio of 2.5: 1 (IgG: BCOAD). E3 was isolated free of BCOAD El and E2 components by (NH4)2SO elution of complex bound to calcium phosphate gel cellulose (Koike & Hamada, 1971;  extracted from BCOAD complex (well 5; 6.5,ug of protein) and a mixture of the remaining proteins extracted from the complex (well 3; 3.5,ug of protein). Reference pig heart lipoamide dehydrogenase is in wells 2, 4 and 6 (11 pug of protein/well). Heffelfinger, 1983). Lines of partial identity can be shown by Ouchterlony double-diffusion precipitation between pig heart lipoamide dehydrogenase and E3 extracted from bovine liver BCOAD, as well as between BCOAD complex and pig heart lipoamide dehydrogenase (Fig. 2) .
Anti-BCOAD Ig can be used to identify the antigen in crude mitochondrial extracts from other mammals. Freeze/thaw salt extracts of bovine and mouse liver mitochondria were quantified by rocket immunoelectrophoresis. Fig. 3 . . .
Branched-chain 2-oxo acid dehydrogenase 343 allowed to react with the anti-BCOAD Ig may be detected by using peroxidase-conjugated goat anti-(rabbit IgG) IgG and diaminobenzidine stain for peroxidase activity. Fig. 4 compares these reaction products from purified BCOAD with that found in mouse liver mitochondrial inner membranes. Each subunit reacts with the anti-BCOAD serum, allowing specific subunit identification from inner membranes of various sources.
Discussion
Antibodies specific for determinants on the multienzyme complex branched-chain 2-oxo acid dehydrogenase were produced in rabbits. In a similar manner, component proteins of the complex, as reported here for the E3 component, are also antigenic. Both sets of antibodies inhibit catalytic activity of native BCOAD. Our laboratory and others have presented data suggesting that the BCOAD complex is structurally and functionally similar to the well-characterized pyruvate dehydrogenase and 2-oxoglutarate dehydrogenase complexes and that all three complexes use a similar E3 flavoprotein (Pettit et al., 1978; Heffelfinger, 1983) . Sakurais et al. (1970) have shown that the E3 components of the pyruvate dehydrogenase and 2-oxoglutarate dehydrogenase complexes are structurally similar and functionally interchangeable. If a common lipoamide dehydrogenase functions in the three complexes, and it is present on the surface of these complexes, then the finding reported here that BCOAD-specific Ig partially inhibits 2-oxoglutarate dehydrogenase would be expected. Similarly, we were able to see weak cross-reactivity between this anti-BCOAD serum and partially purified rabbit liver pyruvate dehydrogenase complex (kindly given by Dr. R. Paxton) by rocket immunoelectrophoresis (results not shown). As expected, the IgG fraction against pig heart lipoamide dehydrogenase also cross-reacted with the rabbit liver pyruvate dehydrogenase complex when tested by this method (results not shown). These results support the fact that E3 is common to these three complexes.
The mechanism for inhibition of catalytic activity does not depend on a precipitating antigenantibody complex. Fab fragments which do not allow the cross-linking necessary for precipitation will bind BCOAD and inhibit catalytic activity. Furthermore, inhibition by antibody was also seen when CO2 production from branched-chain 2-oxo acids by mitochondrial inner membranes was measured. We have not been able to determine whether inhibition by the antibody is due to loss of substrate binding, electron transfer, or some other mechanism. Only when the individual enzyme activities can be quantified in the separated components can we begin to address this question.
The fact that antibodies to native BCOAD are able to cross-react with subunits separated by SDS/polyacrylamide-gel electrophoresis, as shown in Fig. 4 , was somewhat unexpected, since some of the subunits, particularly the E2, are predicted to be buried in the complex. This finding suggests that all four subunits of BCOAD have immunogenic sites which remain antigenic after dissociation. The immunogenic sites on pig heart E3 are similar to the antigenic sites on E3 in native BCOAD, since binding and inactivation of the complex occurs with IgG raised to the pig heart enzyme. Further, the SDS /polyacrylamide -gel-electrophoresis-separated E3 in native BCOAD can be detected by the Western blot technique as a single cross-reacting band at the appropriate molecular weight of native E3.
Having demonstrated that these antibodies will cross-react with different species and tissues, both qualitative and quantitative measurements are possible. As seen with the peroxidase-stained Western blots, the four bands of the complex clearly stain. When applied to fibroblasts cultured from homozygous patients affected with branched-chain 2-oxoacidaemia, this technique can be used to identify which peptides in the complex might be absent or present with a different molecular weight. Only mitochondrial inner-membrane preparations are necessary, so small amounts of fibroblast cultures can be used. As antibodies to the individual subunits become available, quantification with rocket immunoelectrophoresis of the individual peptides will be possible. Currently we can quantify the amount of native enzyme in mitochondrial extracts of a number of tissues. Such quantification with the fibroblasts of branched-chain-2-oxoacidaemia patients will be of value only if gross changes have occurred.
